Works by Hida, Toyoaki

Results: 82

Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation.

Published in:

2017

By:

Yuko Oya;
Tatsuya Yoshida;
Hiroaki Kuroda;
Junichi Shimizu;
Yoshitsugu Horio;
Yukinori Sakao;
Yoshitaka Inaba;
Toyoaki Hida;
Yasushi Yatabe;
Oya, Yuko;
Yoshida, Tatsuya;
Kuroda, Hiroaki;
Shimizu, Junichi;
Horio, Yoshitsugu;
Sakao, Yukinori;
Inaba, Yoshitaka;
Hida, Toyoaki;
Yatabe, Yasushi

Publication type:

journal article

Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 237, doi. 10.1007/s00280-009-1151-1

By:

Yoshitsugu Horio;
Osada, Hirotaka;
Shimizu, Junichi;
Ogawa, Shizu;
Hida, Toyoaki;
Sekido, Yoshitaka

Publication type:

Article

Phase I and pharmacokinetic study of KW-2170, a novel pyrazoloacridone compound, in patients with malignant tumors.

Published in:

2004

By:

Saeki, Toshiaki;
Eguchi, Kenji;
Takashima, Shigemitu;
Sugiura, Takahiko;
Hida, Toyoaki;
Horikoshi, Noboru;
Aiba, Keisuke;
Kuwabara, Takashi;
Ogawa, Makoto

Publication type:

journal article

Anaplastic lymphoma kinase expression in small‐cell lung cancer.

Published in:

Histopathology, 2019, v. 75, n. 1, p. 20, doi. 10.1111/his.13842

By:

Kondoh, Chiaki;
Horio, Yoshitsugu;
Hayashi, Yuko;
Ebi, Hiromichi;
Hida, Toyoaki;
Hasegawa, Yoshinori;
Yatabe, Yasushi

Publication type:

Article

Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

Published in:

Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157

By:

Saka, Hideo;
Nishio, Makoto;
Hida, Toyoaki;
Nakagawa, Kazuhiko;
Sakai, Hiroshi;
Nogami, Naoyuki;
Atagi, Shinji;
Takahashi, Toshiaki;
Horinouchi, Hidehito;
Takenoyama, Mitsuhiro;
Katakami, Nobuyuki;
Tanaka, Hiroshi;
Takeda, Koji;
Satouchi, Miyako;
Isobe, Hiroshi;
Maemondo, Makoto;
Goto, Koichi;
Hirashima, Tomonori;
Minato, Koichi;
Yada, Nobumichi

Publication type:

Article

Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 7, p. 614, doi. 10.1093/jjco/hyz039

By:

Niho, Seiji;
Hosomi, Yukio;
Okamoto, Hiroaki;
Nihei, Keiji;
Tanaka, Hiroshi;
Hida, Toyoaki;
Umemura, Shigeki;
Goto, Koichi;
Akimoto, Tetsuo;
Ohe, Yuichiro

Publication type:

Article

Salvage surgery for small cell lung cancer after chemoradiotherapy.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 4, p. 389, doi. 10.1093/jjco/hyz010

By:

Nakanishi, Keita;
Mizuno, Tetsuya;
Sakakura, Noriaki;
Kuroda, Hiroaki;
Shimizu, Junichi;
Hida, Toyoaki;
Yatabe, Yasushi;
Sakao, Yukinori

Publication type:

Article

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.

Published in:

Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016

By:

Katsuyuki Kiura;
Fumio Imamura;
Hiroshi Kagamu;
Shingo Matsumoto;
Toyoaki Hida;
Kazuhiko Nakagawa;
Miyako Satouchi;
Isamu Okamoto;
Mitsuhiro Takenoyama;
Yasuhito Fujisaka;
Takayasu Kurata;
Masayuki Ito;
Kota Tokushige;
Hatano, Ben;
Makoto Nishio

Publication type:

Article

Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors.

Published in:

Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 322, doi. 10.1093/jjco/hyy026

By:

Makoto Nishio;
Miyako Satouchi;
Atsushi Horiike;
Yoshitsugu Horio;
Yoshinori Sunaga;
Ecstein-Fraisse, Evelyne;
Toyoaki Hida

Publication type:

Article

Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 618, doi. 10.1093/jjco/hyx045

By:

Toyoaki Hida;
Miyako Satouchi;
Kazuhiko Nakagawa;
Takashi Seto;
Shingo Matsumoto;
Katsuyuki Kiura;
Hiroshi Nokihara;
Haruyasu Murakami;
Kota Tokushige;
Ben Hatano;
Makoto Nishio

Publication type:

Article

The Safety and Tolerability of Intravenous ASA404 When Administered in Combination with Docetaxel (60 or 75 mg/m2) in Japanese Patients with Advanced or Recurrent Solid Tumors.

Published in:

Japanese Journal of Clinical Oncology, 2011, v. 41, n. 9, p. 1067, doi. 10.1093/jjco/hyr110

By:

Daga, Haruko;
Hida, Toyoaki;
Ishikawa, Shizu;
Shimizu, Junichi;
Tokunaga, Shinya;
Horio, Yoshitsugu;
Kobayashi, Ken;
Takeda, Koji

Publication type:

Article

Efficacy and Safety of Pemetrexed in Combination with Cisplatin for Malignant Pleural Mesothelioma: A Phase I/II Study in Japanese Patients.

Published in:

Japanese Journal of Clinical Oncology, 2008, v. 38, n. 5, p. 339, doi. 10.1093/jjco/hyn024

By:

Nakagawa, Kazuhiko;
Yamazaki, Koichi;
Kunitoh, Hideo;
Hida, Toyoaki;
Gemba, Kenichi;
Shinkai, Tetsu;
Ichinose, Yukito;
Adachi, Susumu;
Nambu, Yoshihiro;
Saijo, Nagahiro;
Fukuoka, Masahiro

Publication type:

Article

Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study.

Published in:

Cancers, 2021, v. 13, n. 11, p. 2531, doi. 10.3390/cancers13112531

By:

Kuroda, Hiroaki;
Sugita, Yusuke;
Masago, Katsuhiro;
Takahashi, Yusuke;
Nakada, Takeo;
Sasaki, Eiichi;
Sakakura, Noriaki;
Yamaguchi, Rui;
Matsushita, Hirokazu;
Hida, Toyoaki

Publication type:

Article

Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis.

Published in:

2021

By:

Yamaguchi, Teppei;
Shimizu, Junichi;
Hasegawa, Takaaki;
Horio, Yoshitsugu;
Inaba, Yoshitaka;
Hanai, Nobuhiro;
Muro, Kei;
Hida, Toyoaki

Publication type:

journal article

Risk of tumor flare after nivolumab treatment in patients with irradiated field recurrence.

Published in:

2017

By:

Yoshida, Tatsuya;
Furuta, Hiromi;
Hida, Toyoaki

Publication type:

Case Study

Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma.

Published in:

Carcinogenesis, 2012, v. 33, n. 7, p. 1277, doi. 10.1093/carcin/bgs154

By:

Shinjo, Keiko;
Okamoto, Yasuyuki;
An, Byonggu;
Yokoyama, Toshihiko;
Takeuchi, Ichiro;
Fujii, Makiko;
Osada, Hirotaka;
Usami, Noriyasu;
Hasegawa, Yoshinori;
Ito, Hidemi;
Hida, Toyoaki;
Fujimoto, Nobukazu;
Kishimoto, Takumi;
Sekido, Yoshitaka;
Kondo, Yutaka

Publication type:

Article

Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population.

Published in:

Carcinogenesis, 2010, v. 31, n. 4, p. 660, doi. 10.1093/carcin/bgq021

By:

Park, Ji Young;
Matsuo, Keitaro;
Suzuki, Takeshi;
Ito, Hidemi;
Hosono, Satoyo;
Kawase, Takakazu;
Watanabe, Miki;
Oze, Isao;
Hida, Toyoaki;
Yatabe, Yasushi;
Mitsudomi, Tetsuya;
Takezaki, Toshiro;
Tajima, Kazuo;
Tanaka, Hideo

Publication type:

Article

Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells.

Published in:

Carcinogenesis, 2009, v. 30, n. 7, p. 1097, doi. 10.1093/carcin/bgp097

By:

Kawaguchi, Koji;
Murakami, Hideki;
Taniguchi, Tetsuo;
Fujii, Makiko;
Kawata, Shigehisa;
Fukui, Takayuki;
Kondo, Yutaka;
Osada, Hirotaka;
Usami, Noriyasu;
Yokoi, Kohei;
Ueda, Yuichi;
Yatabe, Yasushi;
Ito, Masafumi;
Horio, Yoshitsugu;
Hida, Toyoaki;
Sekido, Yoshitaka

Publication type:

Article

YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation.

Published in:

Carcinogenesis, 2008, v. 29, n. 11, p. 2139, doi. 10.1093/carcin/bgn200

By:

Toshihiko Yokoyama;
Hirotaka Osada;
Hideki Murakami;
Yoshio Tatematsu;
Tetsuo Taniguchi;
Yutaka Kondo;
Yasushi Yatabe;
Yoshinori Hasegawa;
Kaoru Shimokata;
Yoshitsugu Horio;
Toyoaki Hida;
Yoshitaka Sekido

Publication type:

Article

Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case–control study.

Published in:

Carcinogenesis, 2007, v. 28, n. 8, p. 1718, doi. 10.1093/carcin/bgm104

By:

Suzuki, Takeshi;
Matsuo, Keitaro;
Hiraki, Akio;
Saito, Toshiko;
Sato, Shigeki;
Yatabe, Yasushi;
Mitsudomi, Tetsuya;
Hida, Toyoaki;
Ueda, Ryuzo;
Tajima, Kazuo

Publication type:

Article

Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information.

Published in:

Case Reports in Oncology, 2021, v. 14, n. 2, p. 886, doi. 10.1159/000516276

By:

Yamaguchi, Teppei;
Shimizu, Junichi;
Oya, Yuko;
Horio, Yoshitsugu;
Hida, Toyoaki

Publication type:

Article

Different Response to Nivolumab in a Patient with Synchronous Double Primary Carcinomas of Hypopharyngeal Cancer and Non-Small-Cell Lung Cancer.

Published in:

2017

By:

Yamaguchi, Teppei;
Sakurai, Kazuo;
Kuroda, Makoto;
Imaizumi, Kazuyoshi;
Hida, Toyoaki

Publication type:

Case Study

Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.

Published in:

International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 70, doi. 10.1007/s10147-016-1039-0

By:

Yamamoto, Noboru;
Goto, Koichi;
Nishio, Makoto;
Chikamori, Kenichi;
Hida, Toyoaki;
Maemondo, Makoto;
Katakami, Nobuyuki;
Kozuki, Toshiyuki;
Yoshioka, Hiroshige;
Seto, Takashi;
Tajima, Kosei;
Tamura, Tomohide

Publication type:

Article

Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.

Published in:

2017

By:

Yamamoto, Noboru;
Goto, Koichi;
Nishio, Makoto;
Chikamori, Kenichi;
Hida, Toyoaki;
Maemondo, Makoto;
Katakami, Nobuyuki;
Kozuki, Toshiyuki;
Yoshioka, Hiroshige;
Seto, Takashi;
Tajima, Kosei;
Tamura, Tomohide

Publication type:

Erratum

Patterns of recurrence and outcome in patients with surgically resected small cell lung cancer.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 218, doi. 10.1007/s10147-011-0277-4

By:

Ogawa, Shizu;
Horio, Yoshitsugu;
Yatabe, Yasusi;
Fukui, Takayuki;
Ito, Simon;
Hasegawa, Yoshinori;
Mitsudomi, Tetsuya;
Hida, Toyoaki

Publication type:

Article

Genetic alteration of the β-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.

Published in:

Oncogene, 2001, v. 20, n. 31, p. 4249, doi. 10.1038/sj.onc.1204557

By:

Shigemitsu, Kikuo;
Sekido, Yoshitaka;
Usami, Noriyasu;
Mori, Shoichi;
Sato, Mitsuo;
Horio, Yoshitsugu;
Hasegawa, Yoshinori;
Bader, Scott A;
Gazdar, Adi F;
Minna, John D;
Hida, Toyoaki;
Yoshioka, Hiromu;
Imaizumi, Munehisa;
Ueda, Yuichi;
Takahashi, Masahide;
Shimokata, Kaoru

Publication type:

Article

Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis.

Published in:

Oncogene, 2001, v. 20, n. 31, p. 4228, doi. 10.1038/sj.onc.1204561

By:

Kozaki, Ken-ichi;
Koshikawa, Katsumi;
Tatematsu, Yoshio;
Miyaishi, Osamu;
Saito, Hiroko;
Hida, Toyoaki;
Osada, Hirotaka;
Takahashi, Takashi

Publication type:

Article

Interferon-γ differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytes.

Published in:

International Journal of Cancer, 2004, v. 110, n. 3, p. 403, doi. 10.1002/ijc.20139

By:

Tajima, Kouhei;
Ito, Yoshinori;
Demachi, Ayako;
Nishida, Keiko;
Akatsuka, Yoshiki;
Tsujimura, Kunio;
Hida, Toyoaki;
Morishima, Yasuo;
Kuwano, Hiroyuki;
Mitsudomi, Tetsuya;
Takahashi, Toshitada;
Kuzushima, Kiyotaka

Publication type:

Article

Targeted RNA sequencing with touch imprint cytology samples for non‐small cell lung cancer patients.

Published in:

Thoracic Cancer, 2020, v. 11, n. 7, p. 1827, doi. 10.1111/1759-7714.13460

By:

Seto, Katsutoshi;
Masago, Katsuhiro;
Fujita, Shiro;
Haneda, Masataka;
Horio, Yoshitsugu;
Hida, Toyoaki;
Kuroda, Hiroaki;
Hosoda, Waki;
Okubo, Ken‐ichi

Publication type:

Article

Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with <em>ALK</em> rearrangement.

Published in:

Cancer Management & Research, 2018, v. 10, p. 2117, doi. 10.2147/CMAR.S147569

By:

Seto, Katsutoshi;
Kuroda, Hiroaki;
Yoshida, Tatsuya;
Sakata, Shozo;
Mizuno, Tetsuya;
Sakakura, Noriaki;
Hida, Toyoaki;
Yatabe, Yasushi;
Sakao, Yukinori

Publication type:

Article

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.

Published in:

PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161081

By:

Park, Jangchul;
Kobayashi, Yoshihisa;
Urayama, Kevin Y.;
Yamaura, Hidekazu;
Yatabe, Yasushi;
Hida, Toyoaki

Publication type:

Article

Serum glutathione s-transferase-π level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response.

Published in:

Cancer (0008543X), 1994, v. 73, n. 5, p. 1377, doi. 10.1002/1097-0142(19940301)73:5<1377::AID-CNCR2820730511>3.0.CO;2-N

By:

Hida, Toyoaki;
Sugiura, Takahiko;
Kuwabara, Masaki;
Ariyoshi, Yutaka;
Takahashi, Takashi;
Ueda, Ryuzo;
Hosoda, Kenji;
Niitsu, Yoshiro

Publication type:

Article

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy.

Published in:

2020

By:

Tokudome, Nahomi;
Koh, Yasuhiro;
Akamatsu, Hiroaki;
Fujimoto, Daichi;
Okamoto, Isamu;
Nakagawa, Kazuhiko;
Hida, Toyoaki;
Imamura, Fumio;
Morita, Satoshi;
Yamamoto, Nobuyuki

Publication type:

journal article

Asthma caused by durvalumab after chemoradiotherapy in two patients with non‐small cell lung cancer.

Published in:

Respirology Case Reports, 2021, v. 9, n. 9, p. 1, doi. 10.1002/rcr2.835

By:

Uemura, Takehiro;
Fukumitsu, Kensuke;
Maeno, Ken;
Fukuda, Satoshi;
Onuki, Tomohiro;
Kanemitsu, Yoshihiro;
Oguri, Tetsuya;
Niimi, Akio;
Hida, Toyoaki

Publication type:

Article

Successful bronchial arterial infusion chemotherapy combined with radiotherapy for an endobronchial metastasis after resection of small cell lung cancer.

Published in:

Respirology Case Reports, 2021, v. 9, n. 4, p. 1, doi. 10.1002/rcr2.728

By:

Horio, Yoshitsugu;
Sato, Yozo;
Tachibana, Hiroyuki;
Hosoda, Waki;
Shimizu, Junichi;
Hida, Toyoaki

Publication type:

Article

Successful salvage surgery following multimodal therapy in a patient who harboured ALK-rearranged advanced lung adenocarcinoma with multiple organ metastases.

Published in:

Respirology Case Reports, 2019, v. 7, n. 7, p. 1, doi. 10.1002/rcr2.451

By:

Yoshitsugu Horio;
Tetsuya Mizuno;
Yukinori Sakao;
Yoshitaka Inaba;
Yasushi Yatabe;
Toyoaki Hida

Publication type:

Article

Palmoplantar Pustulosis Caused by Immune-Checkpoint Inhibitors.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e829, doi. 10.1016/j.cllc.2021.04.002

By:

Furuta, Hiromi;
Kato, Seiichi;
Masago, Katsuhiro;
Hida, Toyoaki

Publication type:

Article

Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.

Published in:

2018

By:

Hida, Toyoaki;
Kaji, Reiko;
Satouchi, Miyako;
Ikeda, Norihiko;
Horiike, Atsushi;
Nokihara, Hiroshi;
Seto, Takashi;
Kawakami, Tomohisa;
Nakagawa, Shintaro;
Kubo, Toshio

Publication type:

journal article

Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non-Small-Cell Lung Cancer.

Published in:

2016

By:

Nishio, Makoto;
Goto, Koichi;
Chikamori, Kenichi;
Hida, Toyoaki;
Katakami, Nobuyuki;
Maemondo, Makoto;
Ohishi, Norihisa;
Tamura, Tomohide

Publication type:

journal article

Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non--Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2016, v. 17, n. 1, p. 24, doi. 10.1016/j.cllc.2015.07.001

By:

Makoto Nishio;
Koichi Goto;
Kenichi Chikamori;
Toyoaki Hida;
Nobuyuki Katakami;
Makoto Maemondo;
Norihisa Ohishi;
Tomohide Tamura

Publication type:

Article

Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement‑positive non‑small cell lung cancer: A case report.

Published in:

2018

By:

Oya, Yuko;
Yoshida, Tatsuya;
Uemura, Takehiro;
Murakami, Yoshiko;
Inaba, Yoshitaka;
Hida, Toyoaki

Publication type:

Case Study

Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.

Published in:

2020

By:

Papadimitrakopoulou, Vassiliki A.;
Han, Ji‐Youn;
Ahn, Myung‐Ju;
Ramalingam, Suresh S.;
Delmonte, Angelo;
Hsia, Te‐Chun;
Laskin, Janessa;
Kim, Sang‐We;
He, Yong;
Tsai, Chun‐Ming;
Hida, Toyoaki;
Maemondo, Makoto;
Kato, Terufumi;
Jenkins, Suzanne;
Patel, Sabina;
Huang, Xiangning;
Laus, Gianluca;
Markovets, Aleksandra;
Thress, Kenneth S.;
Wu, Yi‐Long

Publication type:

journal article

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.

Published in:

2019

By:

Ahn, Myung‐Ju;
Tsai, Chun‐Ming;
Shepherd, Frances A.;
Bazhenova, Lyudmila;
Sequist, Lecia V.;
Hida, Toyoaki;
Yang, James C. H.;
Ramalingam, Suresh S.;
Mitsudomi, Tetsuya;
Jänne, Pasi A.;
Mann, Helen;
Cantarini, Mireille;
Goss, Glenwood;
Ahn, Myung-Ju;
Tsai, Chun-Ming

Publication type:

journal article

Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.

Published in:

2017

By:

Tanaka, Kosuke;
Hida, Toyoaki;
Oya, Yuko;
Yoshida, Tatsuya;
Shimizu, Junichi;
Mizuno, Tetsuya;
Kuroda, Hiroaki;
Sakakura, Noriaki;
Yoshimura, Kenichi;
Horio, Yoshitsugu;
Sakao, Yukinori;
Yatabe, Yasushi

Publication type:

journal article

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

Published in:

Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144

By:

Satouchi, Miyako;
Nosaki, Kaname;
Takahashi, Toshiaki;
Nakagawa, Kazuhiko;
Aoe, Keisuke;
Kurata, Takayasu;
Sekine, Akimasa;
Horiike, Atsushi;
Fukuhara, Tatsuro;
Sugawara, Shunichi;
Umemura, Shigeki;
Saka, Hideo;
Okamoto, Isamu;
Yamamoto, Nobuyuki;
Sakai, Hiroshi;
Kishi, Kazuma;
Katakami, Nobuyuki;
Horinouchi, Hidehito;
Hida, Toyoaki;
Okamoto, Hiroaki

Publication type:

Article

Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study.

Published in:

Cancer Science, 2021, v. 112, n. 4, p. 1556, doi. 10.1111/cas.14826

By:

Seto, Takashi;
Ohashi, Kadoaki;
Sugawara, Shunichi;
Nishio, Makoto;
Takeda, Masayuki;
Aoe, Keisuke;
Moizumi, Sanae;
Nomura, Satoshi;
Tajima, Takeshi;
Hida, Toyoaki

Publication type:

Article

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

Published in:

Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647

By:

Satouchi, Miyako;
Nosaki, Kaname;
Takahashi, Toshiaki;
Nakagawa, Kazuhiko;
Aoe, Keisuke;
Kurata, Takayasu;
Sekine, Akimasa;
Horiike, Atsushi;
Fukuhara, Tatsuro;
Sugawara, Shunichi;
Umemura, Shigeki;
Saka, Hideo;
Okamoto, Isamu;
Yamamoto, Nobuyuki;
Sakai, Hiroshi;
Kishi, Kazuma;
Katakami, Nobuyuki;
Horinouchi, Hidehito;
Hida, Toyoaki;
Okamoto, Hiroaki

Publication type:

Article

Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer.

Published in:

Cancer Science, 2020, v. 111, n. 12, p. 4442, doi. 10.1111/cas.14605

By:

Kagawa, Yusuke;
Furuta, Hiromi;
Uemura, Takehiro;
Watanabe, Naohiro;
Shimizu, Junichi;
Horio, Yoshitsugu;
Kuroda, Hiroaki;
Inaba, Yoshitaka;
Kodaira, Takeshi;
Masago, Katsuhiro;
Fujita, Shiro;
Niimi, Akio;
Hida, Toyoaki

Publication type:

Article

Lorlatinib in previously treated anaplastic lymphoma kinase‐rearranged non–small cell lung cancer: Japanese subgroup analysis of a global study.

Published in:

Cancer Science, 2020, v. 111, n. 10, p. 3726, doi. 10.1111/cas.14576

By:

Seto, Takashi;
Hayashi, Hidetoshi;
Satouchi, Miyako;
Goto, Yasushi;
Niho, Seiji;
Nogami, Naoyuki;
Hida, Toyoaki;
Takahashi, Toshiaki;
Sakakibara‐Konishi, Jun;
Morise, Masahiro;
Nagasawa, Takashi;
Suzuki, Mie;
Ohkura, Masayuki;
Fukuhara, Kei;
Thurm, Holger;
Peltz, Gerson;
Nishio, Makoto

Publication type:

Article

Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis.

Published in:

Cancer Science, 2019, v. 110, n. 9, p. 2884, doi. 10.1111/cas.14120

By:

Hirashima, Tomonori;
Satouchi, Miyako;
Hida, Toyoaki;
Nishio, Makoto;
Kato, Terufumi;
Sakai, Hiroshi;
Imamura, Fumio;
Kiura, Katsuyuki;
Okamoto, Isamu;
Kasahara, Kazuo;
Uchida, Hirohiko;
Vowler, Sarah L.;
Mitsudomi, Tetsuya

Publication type:

Article